Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.
Create free accountCreate a free account to see past contracts like this one: who won and at what price.
Create free accountTrade Agreement: NONE Tendering Procedures: Attachment: None Competitive Procurement Strategy: N/A - P&A/LOI Only Comprehensive Land Claim Agreement: No Nature of Requirements: The Department of Public Works and Governments Services Canada (PWGSC) is conducting a Request For Information on Canada's requirements for publicly funded seasonal and pandemic influenza vaccine supply, which are currently being met through four (4) contracts awarded in 2011 and 2012. Of these, two (2) contracts, collectively covering the supply of 4.8 M doses annually of seasonal trivalent inactivated influenza vaccine (TIV) and including a provision for accessing back-up supply of pandemic vaccine, will expire at the end of March 2014. A third contract, for the supply of a Live Attenuated Influenza Vaccine (LAIV), will expire at the end of March 2013. Contractual options exist to allow the period of each of these contracts to be extended until March 31, 2015, however, no decision has as yet been made on whether these options will be exercised by Canada. The fourth contract, for the supply of 5 M doses annually of TIV and for the primary supply of pandemic influenza vaccine as and when needed, does not expire until March 31, 2021.
To assist in the decision on exercising these contract options, and to ensure an uninterrupted access to a secure supply of influenza vaccines at competitive prices regardless of whether or not these options are exercised, the Government of Canada, working together with provincial and territorial governments, is now seeking to review and revise, as appropriate, its influenza vaccine supply strategy.
The development of Canada's current strategy was informed, in part, by a consultation with the vaccine industry undertaken in March 2010. In order to assist in reviewing and updating, as necessary, this strategy, Canada is once again seeking input from the vaccine manufacturing industry.
Canada will meet with respondents who indicate in their responses that they wish to participate in a follow-up meeting. Canada currently anticipates holding any such meetings on September 19 - 20, 2012 in Ottawa, Ontario.
Suppliers are to provide an electronic copy of their response to the Contracting Authority by September 14, 2012.
This RFI will not result in the award of any contract.
Delivery Date: Above-mentioned
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Not stated in the notice: procurement type, procurement method, selection criteria, region of delivery, region of opportunity, expected contract period, end user
No attachments listed in the open data.
No contact listed in the open data.